FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

125692007: Recombinant antihemophilic factor agent (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1186041013 Recombinant antihemophilic factor agent (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1207847015 Recombinant antihemophilic factor agent en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3643540017 Recombinant antihemophilic factor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3643541018 Recombinant antihaemophilic factor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4228431000005115 rekombinant antihæmofilifaktorpræparat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    rekombinant antihæmofilifaktorpræparat Is a Product containing antihemophilic factor agent (medicinal product) false Inferred relationship Some
    rekombinant antihæmofilifaktorpræparat Is a Antihemophilic factor agent (substance) false Inferred relationship Some
    rekombinant antihæmofilifaktorpræparat Is a Recombinant protein (substance) false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    rekombinant antihæmofilifaktormiddel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    rekombinant antihæmofilifaktormiddel 1000 IE injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    rekombinant antihæmofilifaktormiddel 1500 IE injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    rekombinant antihæmofilifaktormiddel 250 IE injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    rekombinant antihæmofilifaktormiddel 500 IE injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    rekombinant antihæmofilifaktormiddel 2000 IE injektionsvæske, opløsning, hætteglas a 1 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    rekombinant antihæmofilifaktormiddel 3000 IE, opløsning til injektion, hætteglas a ml injektionsvæske, opløsning, hætteglas ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Recombinant antihemophilic factor agent 2000iu powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Recombinant antihemophilic factor agent 250iu powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Recombinant antihemophilic factor agent 1000iu powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Recombinant antihemophilic factor agent 500iu powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Recombinant antihemophilic factor agent 1500iu powder for injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Moroctocog alfa (substance) Is a False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Susoctocog alfa (substance) Is a False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Octocog alfa (substance) Is a False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Efmoroctocog alfa (substance) Is a False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Turoctocog alfa (substance) Is a False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Lonoctocog alfa (substance) Is a False rekombinant antihæmofilifaktorpræparat Inferred relationship Some
    Recombinant antihaemophilic factor pegylated liposome This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. False rekombinant antihæmofilifaktorpræparat Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start